Sung, Alexander P, Tang, Jennifer J-J, Guglielmo, Michael J et al. · Fatigue : biomedicine, health & behavior · 2020 · DOI
Quick Summary
This study looked at immune cells called NK cells in families where multiple members have ME/CFS. The researchers found that ME/CFS patients and their healthy family members both had fewer of a specific type of NK cell and weaker immune responses compared to unrelated healthy people. This suggests that a genetic weakness in immune cell function might run in families and could increase the risk of developing ME/CFS.
Why It Matters
Understanding genetic immune factors in familial ME/CFS could help identify people at risk before illness develops and guide development of targeted treatments. This study suggests that inherited immune weaknesses—particularly in the NK cell system—may be fundamental to ME/CFS pathogenesis, opening new avenues for research and potential early intervention strategies.
Observed Findings
CFS patients and their unaffected family members both had significantly fewer CD16A-positive NK cells compared to unrelated controls.
Both CFS patients and asymptomatic family members required more antibody stimulation to trigger NK cell killing activity.
Asymptomatic family members predominantly carried the F/F CD16A genetic variant associated with low antibody affinity.
ADCC lytic capacity was reduced in both CFS patients and their family members versus controls.
Combined assessment of NK cell counts and ADCC capacity showed synergistic familial risk when compared to controls.
Inferred Conclusions
Low ADCC capacity may be a genetic risk factor for familial ME/CFS.
Asymptomatic family members share immune abnormalities with affected relatives, suggesting genetic predisposition that may require additional triggers for disease development.
CFGR3A genetic variants encoding low-affinity CD16A receptors may contribute to familial ME/CFS susceptibility.
Characterization of familial CFS provides a valuable opportunity to identify core pathogenic mechanisms underlying ME/CFS.
Remaining Questions
Why do some family members with identical immune deficits remain well while others develop ME/CFS—what additional factors (viral triggers, environmental stressors) determine who gets sick?
What This Study Does Not Prove
This study does not prove that low ADCC causes ME/CFS, only that it is associated with familial cases. It cannot explain why some family members with the same immune weakness develop ME/CFS while others remain well, nor does it address other potential triggers (viral infections, environmental factors) that may be necessary. The small sample size (five families) limits generalizability to the broader ME/CFS population.